Benjamin Gibert

11PUBLICATIONS
107CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 04, 2025
Comprehensive molecular portrait reveals genetic diversity and distinct molecular subtypes of small intestinal neuroendocrine tumors.

Céline Patte, Roxane M Pommier, Anthony Ferrari

|Nov 25, 2024
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O<sup>6</sup>-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET).

Thomas Walter, Thierry Lecomte, Julien Hadoux

|Jul 18, 2024
Netrin signaling mediates survival of dormant epithelial ovarian cancer cells.

Pirunthan Perampalam, James I MacDonald, Komila Zakirova

|Feb 14, 2024
Cooperative pro-tumorigenic adaptation to oncogenic RAS through epithelial-to-mesenchymal plasticity.

Hadrien De Blander, Laurie Tonon, Frédérique Fauvet

|Aug 26, 2023
Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitor.

Benjamin Ducarouge, Anna-Rita Redavid, Camille Victoor

|Mar 06, 2023
From netrin-1-targeted SPECT/CT to internal radiotherapy for management of advanced solid tumors.

David Kryza, Jennifer Wischhusen, Mathieu Richaud

Pageof 2

Frequent Collaborators

6 joint publications

Nicolas Rama

5 joint publications

Patrick Mehlen

3 joint publications

Mathieu Richaud

2 joint publications

Benjamin Ducarouge